BIOLASE, Inc.
BIOLQ
$0.0078
$0.00034.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.43M | -2.80M | -6.49M | -5.33M | -4.59M |
| Total Depreciation and Amortization | 645.00K | 650.00K | 660.00K | 665.00K | 560.00K |
| Total Amortization of Deferred Charges | 117.00K | 117.00K | 955.00K | 106.00K | 329.00K |
| Total Other Non-Cash Items | -967.00K | -1.00M | 486.00K | 839.00K | 267.00K |
| Change in Net Operating Assets | -2.84M | 2.30M | -1.55M | 1.43M | 845.00K |
| Cash from Operations | -4.47M | -734.00K | -5.94M | -2.28M | -2.59M |
| Capital Expenditure | -40.00K | -27.00K | -- | -185.00K | -182.00K |
| Sale of Property, Plant, and Equipment | 74.00K | 87.00K | 197.00K | 182.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 34.00K | 60.00K | 197.00K | -3.00K | -182.00K |
| Total Debt Issued | 2.50M | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | -700.00K | -165.00K | -165.00K | -- |
| Issuance of Common Stock | -- | 2.00K | 2.79M | 1.05M | 0.00 |
| Repurchase of Common Stock | -10.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 270.00K | -- | 0.00 | 2.93M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | 3.02M | 0.00 | 825.00K |
| Cash from Financing | 2.49M | -428.00K | 5.65M | 885.00K | 3.76M |
| Foreign Exchange rate Adjustments | 120.00K | -19.00K | -79.00K | 158.00K | -107.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.83M | -1.12M | -173.00K | -1.24M | 879.00K |
